The Vanguard Group 13D and 13G filings for Oncternal Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Oncternal Therapeutics, Inc. ONCT |
The Vanguard Group | 2,860,906 4.850% |
2,860,906 (New Position) |
Filing |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Oncternal Therapeutics, Inc. ONCT |
The Vanguard Group | 143,207 5.080% |
143,207 (New Position) |
Filing |